The Elav-like Proteins Bind to a Conserved Regulatory Element in the 3'-Untranslated Region of GAP-43 mRNA*

(Received for publication, October 23, 1996, and in revised form, January 6, 1997)

Sangmi Chung Dagger , Michael Eckrich Dagger , Nora Perrone-Bizzozero §, Douglas T. Kohn § and Henry Furneaux Dagger

From the Dagger  Program in Molecular Pharmacology and Therapeutics, Memorial Sloan Kettering Cancer Center, New York, New York 10021 and the § Department of Biochemistry, University of New Mexico School of Medicine and Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

Previous studies have identified three brain proteins (40, 65 and 95 kDa, respectively) that specifically bind to the 3'-untranslated region of GAP-43 mRNA. In this study, using a specific monoclonal antibody, we now show that the 40-kDa proteins are members of the Elav-like protein family. This family of specific RNA-binding proteins comprise three neural specific members called HuD, HuC, and Hel-N1. We have shown that purified recombinant HuD can bind with high affinity to GAP-43 mRNA. In addition, we have mapped the binding site to a highly conserved 26-nucleotide sequence within the regulatory element. The binding of HuD to this site is readily displaced by RNA oligonucleotides encoding other HuD binding sites. We also show that only the first and second RNA binding domains of HuD are required for selective binding to GAP-43 mRNA.


INTRODUCTION

The Elav-like genes encode a family of RNA-binding proteins that were first described in Drosophila (1-3). Elav, the founder member of this family, is expressed immediately after neuroblastic differentiation into neurons (4). The Elav gene product is necessary for neuronal differentiation and maintenance. In mutant flies, neuroblasts fail to differentiate and continue to proliferate (1). Interest in these proteins was stimulated by the discovery that their human homologues are tumor antigens (5). Subsequent cloning studies have shown that there are four members of the human Elav-like family, namely, HuD, HuC, Hel-N1, and HuR (5-8). HuD, HuC, and Hel-N1 are expressed in postmitotic neurons and in neuroendocrine tumors (6, 9-12). Recent studies indicate that they are also required for neuronal differentiation (13). HuR, the fourth and most recently discovered member, is expressed in all cells and is overexpressed in many human tumors (7). Its normal cellular function has yet to be clarified.

All four Elav-like proteins contain three RNA recognition motifs (RRM)1 of the RNP2/RNP1 type (14). The first and second of these RRMs are in tandem and are separated from the third by a segment rich in basic amino acids. A significant insight into the mechanism of action of these proteins was provided by the observation that they specifically bind to U-rich elements in the 3'-UTR of mRNAs that regulate cell growth and differentiation (7, 12, 15-17).2 These elements were first characterized by Shaw and Kamen (19), who showed that the U-rich element in the 3'-UTR of granulocyte macrophage-colony-stimulating factor mRNA regulates expression at the post-transcriptional level. Recent data have shown that transfection of the Elav-like genes into cells results in the increase in expression of mRNAs that contain such U-rich elements (20). Thus, through binding to a common element in many mRNAs, the Elav-like proteins are important components of coordinate gene expression mechanisms.

One important question is the relationship between the HuR, which is ubiquitously expressed, and the neural specific members HuD, HuC, and Hel-N1. It is reasonable to postulate that HuD, HuC, and Hel-N1 interact with brain-specific mRNAs involved in pathways critical to neuronal differentiation. In our previous studies we have investigated the interaction between the Elav-like proteins and mRNAs that are expressed in all cells (16-17, 21).2 We have now investigated whether there are neuronal specific mRNAs that may be specifically regulated by the Elav-like proteins. Recent studies have indicated that post-transcriptional mechanisms significantly contribute to the regulation of GAP-43 gene expression (22-24). GAP-43 is a neuron-specific phosphoprotein that is required for the regeneration and remodeling of neuronal connections (25-34). Precise control of GAP-43 expression is thus of critical importance during nervous system development.

Two independent cis-acting elements that regulate expression have been mapped to the 3'-UTR of GAP-43 mRNA. One maps to the region proximal to the termination codon (35). Insertion of this element into a reporter mRNA results in destabilization of the reporter message (36). This pathway is regulated by nerve growth factor (36). The other element is U-rich in sequence and found within a highly conserved region of the 3'-UTR (37). Insertion of this element also confers instability to reporter constructs, which is reversed by treatment with TPA (38). Thus GAP-43 expression is regulated by at least two different pathways utilizing at least two different cis-acting elements. Cross-linking studies have identified three brain proteins of 40, 65, and 95 kDa that specifically interact with the 3'UTR of GAP-43 mRNA (37). It was noted that the 40-kDa protein was similar in size to the neuronal specific Elav-like proteins. Thus, in the current study, we have investigated whether this 40-kDa protein corresponds to a neuronal specific member of the Elav-like protein family and have investigated its interaction with GAP-43 mRNA in a purified system.


MATERIALS AND METHODS

Preparation of Labeled RNA Transcripts

Plasmid DNAs were digested with the appropriate restriction enzymes and transcribed with T3 RNA polymerase for GAP-43B, and GAP-43C or T7 RNA polymerase for GAP-43A in the presence of [32P]uridine triphosphate (Amersham Corp.) as described previously (39). pGAP43A was linearized with HindIII, yielding a transcript of 718 nucleotides containing coding region and part of 3'-untranslated region. pGAP43B and pGAP43C were linearized with EcoRI, yielding 221 nucleotides and 114 nucleotides of the 3'-untranslated region, respectively.

Immunoprecipitation of UV-cross-linked Complexes between the GAP-43 3'-UTR and Cytosolic Proteins from Neonatal Rat Brains

S100 extracts were prepared from freshly dissected brains from postnatal day 4 rats as described by Dignam et al. (40). Extracts containing 50 µg of protein were incubated with 0.5 ng of 32P-labeled RNA (1.5 × 105 cpm) and 10 units of RNasin (Promega) in a buffer containing 10 mM HEPES (pH 7.6), 3 mM MgCl2, 40 mM KCl, 5% (v/v) glycerol, and 1 mM dithiothreitol for 10 min at 4 °C (41). Following digestion with RNase T1 (1 unit/µl, Calbiochem), RNA-protein complexes were exposed to UV irradiation for 30 min at 4 °C using a germicidal lamp (Sylvania G30T8), and samples were then subjected to an additional digestion with RNase A (1 mg/ml) for 15 min at 37 °C. Immunoprecipitation assays were performed using 16A11 mAb (10) or an anti-tubulin mAb as a negative control. We used the protocol developed by De Graan et al. (42) with the following modifications. UV-cross-linked complexes were incubated in 200 µl of Nonidet P-40 buffer (10 mM Tris-HCl (pH 7.5), 1% Nonidet P-40, 1% bovine serum albumin, 150 mM NaCl, and 2 mM EDTA) containing the indicated mAb (at 1:100 dilution) for 1 h at 25 °C. Next, 20 µl of a 50% slurry of protein G-Sepharose (Sigma) in Nonidet P-40 buffer was added. Samples were further incubated for 4 h at 4 °C; beads containing the immunoprecipitates were then separated by centrifugation and proteins analyzed by 10% SDS-polyacrylamide gel electrophoresis. Gels were dried and the radioactivity associated with each band analyzed using a PhosphorImager (Molecular Dynamics).

Purification of GST-HuD Proteins

An overnight culture of Escherichia coli BL 21, transformed with each HuD construct (17), was diluted in 1:50 LB media. At an A600 of 0.4, the culture was induced with isopropyl-beta -D-thiogalactopyranoside (0.1 mM). After 4 h of further growth, cells were spun down and resuspended in 10 ml of buffer A (50 mM Tris (pH 8.0), 200 mM NaCl, 1 mM EDTA). The cells were lysed by adding lysozyme (0.2 mg/ml) and Triton (1%). The lysate was centrifuged at 12,000 × g for 30 min. The resultant supernatant was loaded onto a glutathione-agarose affinity column (13 mg of protein/ml of resin). After washing the column with buffer B (50 mM Tris (pH 8.0), 200 mM NaCl, 1 mM EDTA, 1% Triton), GST-HuD was eluted with (50 mM Tris (pH 8.0), 5 mM glutathione). Active protein was determined by RNA-complex formation, pooled, and stored at -70 °C.

Assay of GAP-43-HuD Complex Formation

Reaction mixtures (0.02 ml) contained 50 mM Tris (pH 7.0), 150 mM NaCl, 0.25 mg/ml tRNA, 0.25 mg/ml bovine serum albumin, 10 fmol of labeled RNA and protein as indicated. Mixtures were incubated at 37 °C for 10 min. Following incubation, 4 µl of a dye mixture (50% glycerol, 0.1% bromphenol blue, 0.1% xylene cyanol) was added, and 20% of the reaction mixture was immediately loaded on a 1% agarose gel in TAE buffer (40 mM Tris acetate, 1 mM EDTA). The gel was then electrophoresed at 40 V for 2.5 h. The gel was dried on DE81 (Whatman) with a backing of gel drying paper (Hudson City Paper, West Caldwell, NJ) and exposed to XAR5 film (Eastman Kodak Co.) for 4-5 h at -70 °C.

RNase T1 Selection Assay

Reaction mixtures (0.02 ml) contained 50 mM Tris (pH 7.0), 150 mM NaCl, 0.25 mg/ml bovine serum albumin, 0.25 mg/ml tRNA, 20 fmol of radiolabeled mRNA, purified HuD as indicated. After 10 min of incubation at 37 °C, 0.5 unit of RNase T1 was added to each reaction and incubated at 37 °C for 10 min further. The mixtures were diluted 1:6 with buffer F (20 mM Tris (pH 7.0), 150 mM NaCl, 0.05 mg/ml tRNA) and filtered through nitrocellulose (BA 85, Schleicher & Schüll). After washing the nitrocellulose twice with buffer F, bound HuD-RNA complex was extracted with phenol/chloroform and concentrated by ethanol precipitation. The resultant RNA was dissolved in formamide buffer and denatured at 65 °C for 2 min. Samples were analyzed by 12% polyacrylamide/urea gel electrophoresis. The gel was fixed with 1:1:8 acetic acid:methanol:water, dried, and exposed to the XAR5 film at -70 °C overnight.

Nitrocellulose Filter Binding Assay

Reaction mixtures (0.02 ml) contained 50 mM Tris (pH 7.0), 150 mM NaCl, 0.25 mg/ml bovine serum albumin, 0.25 mg/ml tRNA, 10 fmol of radiolabeled mRNA, and purified HuD as indicated. After 10 min of incubation at 37 °C, the mixtures were diluted 1:6 with buffer F and filtered using nitrocellulose. After washing the filter twice with buffer F, bound radioactivity was determined by Cerenkov counting.


RESULTS

The 40-kDa Protein Is Recognized by a Monoclonal Antibody Directed against the Neuronal Members of the Elav-like Protein Family

Fig. 1 shows the structure of the GAP-43 mRNA and the transcripts (encoded by plasmids GAP-43H, GAP-43A, GAP-43C, and GAP-43B) used in these studies. Kohn et al. (37) have previously described 40, 65, and 90-kDa brain proteins that cross-link to the transcript encoded by plasmid GAP-43H. To investigate whether the 40-kDa protein was related to the Elav-like proteins, the labeled cross-linked material was precipitated with a monoclonal antibody specific for the neuronal members of the Elav-like protein family (10). The anti-Elav-like monoclonal (16A11) specifically precipitated the 40-kDa species (Fig. 2, lanes 1-3). The 40-kDa protein was not detected without added mAb nor precipitated on addition of an irrelevant monoclonal antibody. Thus we concluded that the previously characterized 40-kDa RNA binding factor is indeed a member of the neuronal Elav-like protein family. The 65- and 95-kDa proteins were not co-precipitated. This result indicates that there is little protein-protein interaction between the 40-kDa protein and the 65- and 95-kDa proteins. It is possible, however, that they interact when bound to RNA. In this experiment the complex was digested with RNase before immunoprecipitation.


Fig. 1. The structure of GAP-43 mRNA and DNA plasmids used to synthesize indicated segments of GAP-43 mRNA. The full-length GAP-43 mRNA is shown, indicating the 5'-UTR followed by the open reading frame (open box) and the 3'-UTR and poly(A) tail. The location of the individual plasmids (GAP-43H, GAP-43A, GAP-43B, and GAP-43C) is shown. The sequence of GAP-43B is displayed and the the 26-nucleotide HuD binding site is in bold type.
[View Larger Version of this Image (15K GIF file)]



Fig. 2. The 40-kDa species is a member of the Elav-like RNA-binding protein family. 0.5 ng of 32P-labeled GAP-43 RNA (derived from plasmid GAP-43H) was incubated with S100 extract (50 µg of protein) and cross-linked by UV irradiation. The cross-linked material was then precipitated with mAb 16A11 or an anti-tubulin mAb and analyzed by SDS-gel electrophoresis (lanes 1-3). The nonprecipitated material is shown in lane 4.
[View Larger Version of this Image (35K GIF file)]


There are three neuronal members of the Elav-like protein family, namely HuD, HuC, and Hel-N1. (5, 6, 8) The present analysis cannot establish whether a particular family member is associated with GAP-43 mRNA. mAb 16A11 recognizes all three. Since, however, the RNA binding properties of all three are virtually identical (12, 17), and GAP-43 is expressed in virtually all neurons, it is likely that all three family members associate with GAP-43 mRNA.

Characterization of HuD-GAP-43 mRNA Complex Formation

Although it is clear that the Elav-like proteins are bound to GAP-43 mRNA, it is possible that other factors in the extract are required to stabilize binding. Thus we have investigated whether purified Elav-like proteins can bind to GAP-43 mRNA. For these studies, we have chosen HuD, since its RNA binding properties have been documented previously (17). Purified recombinant HuD was incubated with labeled transcripts and complex formation was assayed by gel retardation analysis. HuD binds with high affinity to the transcripts encoded by GAP-43B and GAP-43H (Gap-43H data are not shown), but not to transcripts encoded by GAP-43A or GAP-43C (Fig. 3). GAP-43A contains the entire coding region and the cis-acting element defined by Nishizawa et al. (35) GAP-43B contains the cis-acting element defined by Tsai et al. (38). Thus, purified HuD is sufficient to reconstitute binding and the specificity of that binding correlates well with the known properties of the 40-kDa factor (38).


Fig. 3. HuD binds to the GAP-43 RNA 3'-untranslated region. 10 fmol (50,000 cpm/pmol UMP) of each 32P-labeled RNA was incubated without protein or with indicated concentrations of HuD protein. After 10 min of incubation at 37 °C, 20% of the reaction mixtures was resolved on a 1% agarose gel.
[View Larger Version of this Image (35K GIF file)]


The interaction between HuD and GAP-43B RNA was further investigated using a quantitative RNA binding assay. We employed the same method as originally used for the R17 coat protein (43). A low concentration of labeled RNA (100 pM) was incubated with increasing concentrations of HuD protein as indicated. The reactions were filtered through nitrocellulose and the bound radioactivity determined. Fig. 4A shows that the formation of the GAP-43B RNA-HuD complex is detectable at 7.2 nM, has a midpoint at about 130 nM, and reaches a plateau above 720 nM with about 60% of the input RNA bound. Complex formation with GAP-43A or GAP-43C RNA was not detectable under these conditions. A plot of the log of complex/free RNA versus the log of HuD concentration reveals a straight line with an intersect on the x axis at 129 nM (Fig. 4B). Thus the binding of HuD to GAP-43 mRNA is a simple molecular reaction with an apparent Kd of 129 nM.


Fig. 4. The affinity of HuD for GAP-43 RNA. RNA-protein complex formation was assayed by nitrocellulose filtration. 10 fmol of each RNA (specific activity, 100,000 cpm/pmol) was incubated with the indicated concentration of HuD for 10 min at 37 °C. A, plot of percentage of RNA bound versus log of HuD concentration. black-diamond , GAP-43A; bullet , GAP-43B; square , GAP-43C. B, plot of log complex/free RNA versus log HuD concentration.
[View Larger Version of this Image (12K GIF file)]


HuD Binds to a Conserved U-rich Segment of GAP-43 mRNA

We have further mapped the binding site using an RNase T1 digestion technique. In this technique the HuD-RNA complex is digested with RNase T1, and the protein bound RNA fragments are isolated by absorption to nitrocellulose (17). Fig. 5A shows the HuD-dependent retention of a single fragment on incubation with GAP-43B RNA. No fragments were selected from GAP-43A or GAP-43C RNAs. This fragment is identical in size to a unique 26-nucleotide T1 fragment present in the total digest of GAP-43B RNA. This suggested that this fragment is the HuD binding site. It was also conceivable, however, that it arose from the protection of a G residue between two smaller T1 oligonucleotides, yielding a fragment of similar size. The 26-nucleotide fragment was isolated and redigested with RNase T1 (Fig. 5B). No digestion products were observed, therefore this fragment indeed corresponds to the unique 26-nucleotide sequence that is shown in Fig. 1. It is interesting to note that this binding site is highly conserved between GAP-43 mRNAs from different species (37).


Fig. 5. HuD binds to a conserved element in the 3'-UTR of GAP-43 mRNA. A, the indicated concentrations of HuD or glutathione S-transferase (GST) (lanes 1, 2, 4, 5, 7, and 8) were incubated with 32P-labeled Gap-43 RNAs (20 fmol, 50,000 cpm/pmol UTP) at 37 °C for 10 min. After treating the reaction mixture with T1 RNase (0.5 unit per reaction), the reaction mixtures were filtered through nitrocellulose. The bound RNA fragments were extracted and resolved on 12% denaturing polyacrylamide gel. Lane M, phi X174 HinfI fragments; lane 3, RNase T1 digestion of GAP-43A RNA; lane 6, RNase T1 digestion of GAP-43B; lane 9, RNase T1 digestion of Gap-43C. B, the selected fragment was eluted from the preparative gel and analyzed by further digestion with RNase T1.
[View Larger Version of this Image (48K GIF file)]


We have compared the sequence of the GAP-43 mRNA binding site with those we have found found in c-Fos, c-Myc, Tau, interleukin-3, and AdIVA2 mRNAs (Fig. 6). The GAP-43 binding site is similar to the others in that it contains U-rich tracts. We have shown that these U-rich tracts are essential for the binding of HuD to the element in the 3'-UTR of c-Fos mRNA (17). Next, we tested whether the HuD-GAP-43 complex would be displaced by the 27-nucleotide c-Fos binding site. Complex formation was indeed readily displaced by the 27-nucleotide c-Fos oligonucleotide but not by a mutant oligonucleotide (27-8) (17) which contains substitutions of the U-rich tracts (Fig. 7). Thus the GAP-43 binding site is functionally similar to those we have described in other mRNAs.


Fig. 6. A comparison of various HuD binding sites. The binding sites in c-Fos, interleukin-3, c-Myc, Tau, IVA2, and GAP-43 mRNAs are shown. U tracts are underlined.
[View Larger Version of this Image (20K GIF file)]



Fig. 7. Competition analysis. 10 fmol (50,000 cpm/pmol UTP) of 32P-labeled GAP-43B RNA was incubated with 240 nM HuD protein. The indicated molar excess of "27" (containing c-Fos ARE sequences) or "27-8" (irrelevant competitor) was added into the reaction. After 10 min of incubation at 37 °C, 20% of reaction mixtures was resolved on a 1% agarose gel.
[View Larger Version of this Image (51K GIF file)]


The First and Second RNA Binding Domains Are Essential for Binding to GAP-43 mRNA

HuD contains three RNA binding domains (5). The first and second are in tandem and are separated from the third by a basic segment, which we call the basic domain. Previous studies have shown that the first and second RNA binding domains are both essential for binding to the AU-rich elements, whereas the third RNA binding domain binds to the poly(A) tail (17).2 To determine the domains of HuD required for binding to GAP-43 mRNA, we utilized the deletion constructs shown in Fig. 8. Gel retardation analysis showed that the first and second RRMs were essential for binding to the GAP-43 site (Fig. 8). The third RRM did not display any detectable binding (Fig. 8, lanes 8 and 9). As noted previously in our studies on the c-Fos element, the first and second RRMs are required in tandem for complete binding activity (Fig. 8, lanes 4-6). The basic domain alone did not exhibit any binding activity.


Fig. 8. Analysis of RNA binding domains. A, HuD deletion mutants (240 nM) were incubated with 10 fmol of 32P-labeled GAP-43B RNA (50,000 cpm/pmol UTP). Following incubation at 37 °C for 10 min, 20% of the reaction mixtures were resolved on 1% agarose gel. B, structure of the mutant HuD derivatives. The residues of HuD contained in each construct are as follows. For pGEX-HuDIIIB, 2-268; for pGEX-HuDI, 28-136; for pGEX-HuDII, 110-216; for pGEX-HuDB, 201-297; for pGEX-HuDBIII, 245-373; for pGEX-HuDIII, 279-373.
[View Larger Version of this Image (31K GIF file)]



DISCUSSION

The Elav-like RNA-binding proteins regulate gene expression via an interaction with U-rich elements in the 3'-UTR of specific mRNAs. The mechanism underlying the specificity of this regulation is poorly understood. There are four members of this family (HuD, HuC, Hel-N1, and HuR) in human cells. HuR is ubiquitously expressed, whereas HuD, HuC and Hel-N1 are selectively expressed in neurons (5-8). The neuronal members are the homologues of Elav, a Drosophila gene required for neuronal differentiation. (2) The existence of three family members in human neurons suggests that they specifically modulate mRNAs that regulate neuronal differentiation. The RNA binding specificity, however, of all four members is very similar (7, 12, 17). Thus, it is likely that HuD, HuC, and Hel-N1 exert their function, not only through binding to U-rich elements, but also through interactions with other proteins that selectively bind to the 3'-UTR of neuronal mRNAs. The first step in investigating this is to identify and study neuronal specific mRNAs that may be regulated by the Elav-like proteins. Previous studies have shown that neuronal factors of 40, 65, and 95 kDa bind specifically to the 3'-UTR of GAP-43 mRNA. (37, 38) GAP-43 is an important neuronal specific protein that regulates synaptic remodeling (18, 30, 44). In this study we have shown that the 40-kDa factor is a neuronal specific member of the Elav-like protein family. We have shown that purified HuD binds to GAP-43 mRNA with appropriate specificity and affinity. Thus it is likely that the Elav-like proteins play a significant role in the post-transcriptional control of GAP-43 expression. If this was so, then one would expect that alteration of Elav-like gene expression would affect GAP-43 expression. In addition one might suspect that deletion of the Elav-like binding site from GAP-43 mRNA would significantly affect its expression. These are important future experiments to confirm the role of the Elav-like proteins in the regulation of GAP-43 expression.

The regulation of GAP-43 expression in PC12 cells illuminates the specificity problem that we discussed above. Addition of TPA to PC12 cells results in the marked stabilization of GAP-43 mRNA (38). This stabilization is effected through interactions with the segment of GAP-43 mRNA encoded by plasmid GAP-43B. However, TPA treatment also results in the increased degradation of many other mRNAs (e.g. c-Fos) that contain U-rich elements and are selectively bound by the Elav-like proteins. The simplest hypothesis is that the regulation of a particular mRNA may be governed by the association of the Elav-like proteins with other RNA-binding proteins that recognize disparate specificity elements in the mRNA. In this paper we have defined the 26-nucleotide Elav-like binding site. This site is well conserved between GAP-43 mRNAs from different species. There are, however, additional elements within the sequence encoded by GAP-43B (Fig. 1) that are also well conserved. It is reasonable to assume that these elements and their associated binding factors also play a role in the expression of GAP-43 mRNA. The 95-kDa protein described by Tsai et al. (38) is a good candidate for such a trans-acting factor. Thus, the TPA-induced stabilization of GAP-43 mRNA may depend on the binding of the 95-kDa protein, the binding of the Elav-like proteins to the 26-nucleotide element, and appropriate interactions between these two proteins. Further investigation of this possibility will require the purification of the 95-kDa factor. It is also important to point out that GAP-43 mRNA contains another element at the 3' end of the open reading frame. This element is bound by the 65-kDa factor (38). It remains to be seen whether there is any interaction between the 65-kDa factor and the Elav-like proteins. In conclusion, the GAP-43-Elav-like protein complex described here will provide an important reagent to answer these questions and may facilitate the development of an in vitro system that faithfully recapitulates regulation of GAP-43 mRNA turnover.


FOOTNOTES

*   This work was supported by National Institutes of Health Grants NS29682 (to H. M. F.) and NS30255 (to N. P. B.) and by National Cancer Institute Core Grant P30-CA08748.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed: Box 20, Laboratory of Molecular Neuro-oncology, Program in Molecular Pharmacology and Therapeutics, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Tel.: 212-639-8701; Fax: 212-639-2861; E-mail: h-furneaux{at}ski.mskcc.org.
1   The abbreviations used are: RRM, RNA recognition motif; UTR, untranslated region; TPA, 12-O-tetradecanoylphorbol-13-acetate; mAb, monoclonal antibody.
2   W.-J. Ma, S. Chung, and H. M. Furneaux, submitted for publication.

Acknowledgment

We thank Barry Nevins for his patience in preparing the manuscript.


REFERENCES

  1. Campos, A. R., Grossman, D., and White, K. (1985) J. Neurogenet. 2, 197-218 [Medline] [Order article via Infotrieve]
  2. Robinow, S., Campos, A. R., Yao, K. M., and White, K. (1988) Science 242, 1570-1572 [Medline] [Order article via Infotrieve]
  3. Homyk, J., T., Isono, K., and Pak, W. L. (1985) J. Neurogenet. 2, 309-324 [Medline] [Order article via Infotrieve]
  4. Robinow, S., and White, K. (1991) J. Neurobiol. 22, 443-461 [Medline] [Order article via Infotrieve]
  5. Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M. R., Wong, E., Henson, J., Posner, J. B., and Furneaux, H. M. (1991) Cell 67, 325-333 [Medline] [Order article via Infotrieve]
  6. King, P. H., Levine, T. D., Fremeau, R. T., and Keene, J. D. (1994) J. Neurosci. 14, 1943-1952 [Abstract]
  7. Ma, W.-J., Cheng, S., Wright, A., Campbell, C., and Furneaux, H. M. (1996) J. Biol. Chem. 271, 8144-8151 [Abstract/Free Full Text]
  8. Sakai, K., Gofuku, M., Kitagawa, Y., Ogasawara, T., Hirose, G., Yamazaki, M., Koh, C., Yanagisawa, N., and Steinman, L. (1994) Biochem. Biophys. Res. Commun. 199, 1200-1208 [CrossRef][Medline] [Order article via Infotrieve]
  9. Dalmau, J., Furneaux, H. M., Cordon-Cardo, C., and Posner, J. B. (1992) Am. J. Pathol. 141, 1-6
  10. Marusich, H. M., Furneaux, H. M., Henion, P., and Weston, J. A. (1994) J. Neurobiol. 25, 143-155 [Medline] [Order article via Infotrieve]
  11. Barami, K., Iversen, K., Furneaux, H., and Goldman, S. (1995) J. Neurobiol. 28, 82-101 [Medline] [Order article via Infotrieve]
  12. Gao, F. B., Carson, C., Levine, T., and Keene, J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11207-11211 [Abstract/Free Full Text]
  13. Jain, R. G., Andrews, L. G., McGowan, K. M., Pekala, P. H., and Keene, J. D. (1997) Mol. Cell. Biol. 17, 954-962 [Abstract]
  14. Kenan, D. J., Query, C. C., and Keene, J. D. (1991) Trends Biochem. Sci. 16, 214-220 [CrossRef][Medline] [Order article via Infotrieve]
  15. Levine, T. D., Gao, F., King, P. H., Andrews, L. C., and Keene, J. D. (1993) Mol. Cell. Biol. 13, 3494-3504 [Abstract]
  16. Liu, J., Dalmau, J., Szabo, A., Rosenfeld, M., Huber, J., and Furneaux, H. (1995) Neurology 45, 544-550 [Abstract]
  17. Chung, S., Jiang, L., Cheng, S., and Furneaux, H. M. (1996) J. Biol. Chem. 271, 11518-11524 [Abstract/Free Full Text]
  18. Yankner, B. A., Benowitz, L. I., Villa-Komaroff, L., and Neve, R. L. (1990) Mol. Brain Res. 7, 39-44 [Medline] [Order article via Infotrieve]
  19. Shaw, G., and Kamen, R. (1986) Cell 46, 659-667 [Medline] [Order article via Infotrieve]
  20. Andrews, L. G., Jain, R. G., Keene, J. D. & Pekala, P. H. (1996) in Overexpression of the RNA-binding Protein Hel-N1 in 3T3-L1 Adipocytes Results in Accelerated Differentiation and Increased GLUT1 Expression, Keystone Symposia, on Molecular and Cellular Biology, March 11-17, Hilton Head, SC Abstr. 400
  21. Ma, W.-J. & Furneaux, H. (1996) Hum. Genet., in press
  22. Federoff, H. J., Grabczyk, E., and Fishman, M. C. (1988) J. Biol. Chem. 263, 19290-19295 [Abstract/Free Full Text]
  23. Perrone-Bizzozero, N., Neve, R., Irwin, N., Lewis, S., Fischer, I., and Benowitz, L. (1991) Mol. Cell. Neurosci. 2, 402-409
  24. Perrone-Bizzozero, N. I., Cansino, V. V., and Kohn, D. T. (1993) J. Cell Biol. 120, 1263-1270 [Abstract]
  25. Benowitz, L. I., and Routtenberg, A. (1987) Trends Neurosci. 10, 527-532 [CrossRef]
  26. Benowitz, L. I., Rodriguez, W. R., and Neve, R. L. (1990) Mol. Brain Res. 8, 17-23 [Medline] [Order article via Infotrieve]
  27. Jacobson, R. D., Virag, I., and Skene, J. H. P. (1986) J. Neurosci. 6, 1843-1855 [Abstract]
  28. McGuire, C. B., Snipes, G. J., and Norden, J. J. (1988) Dev. Brain Res. 41, 277-291
  29. Dani, J. W., Armstrong, D. M., and Benowitz, L. I. (1990) Neuroscience 40, 277-288
  30. Zuber, M. X., Goodman, D. W., Karns, L. R., and Fishman, M. C. (1989) Science 244, 1193-1195 [Medline] [Order article via Infotrieve]
  31. Benowitz, L. I., and Perrone-Bizzozero, N. (1991) Prog. Brain Res. 89, 69-87 [Medline] [Order article via Infotrieve]
  32. Skene, J. H. P. (1989) Annu. Rev. Neurosci. 12, 127-156 [CrossRef][Medline] [Order article via Infotrieve]
  33. Nelson, R. B., and Routtenberg, A. (1985) Exp. Neurol 89, 213-224 [Medline] [Order article via Infotrieve]
  34. Brain Res. 328, 381-385Gispen, W. E. Brain Res. 328, 381-385
  35. Nishizawa, K., and Okamoto, H. (1994) Biochem. Biophys. Res. Commun. 205, 1380-1385 [CrossRef][Medline] [Order article via Infotrieve]
  36. Nishizawa, K. (1994) Biochem. Biophys. Res. Commun. 200, 789-796 [CrossRef][Medline] [Order article via Infotrieve]
  37. Kohn, D. T., Tsai, K. C., Cansino, V. V., Neve, R. L., and Perrone-Bizzozero, N. I. (1996) Mol. Brain Res. 36, 240-250 [Medline] [Order article via Infotrieve]
  38. Tsai, K.-C., Casino, V. V., Kohn, D. T., Neve, R. & Perrone-Bizzozero, N. I. (1997) J. Neurosci., in press
  39. Furneaux, H. M., Perkins, K. K., Freyer, G. A., Arenas, J., and Hurwitz, J. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 4351-4355 [Abstract]
  40. Dignam, J., Lebovitz, R. M., and Roeder, R. D. (1983) Nucleic Acids Res. 11, 1475-1489 [Abstract]
  41. Liebold, E. A., and Munro, H. N. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2171-2175 [Abstract]
  42. De Graan, P. N., Dekker, L. V., Oestreicher, A. B., Van der Voorn, L., and Gispen, W. H. (1989) J. Neurochem. 52, 17-23 [Medline] [Order article via Infotrieve]
  43. Carey, J., Cameron, V., de Haseth, P. L., and Uhlenbeck, O. C. (1983) Biochemistry 22, 2601-2610 [Medline] [Order article via Infotrieve]
  44. Strittmatter, S. M., Fankhauser, C., Huang, P. L., Mashimo, H., and Fishman, M. C. (1995) Cell 80, 445-452 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.